On a significant note, the U.S. Food and Drug Administration has approved a revolutionary device designed to continuously monitor both blood sugar levels and ketone levels in people with diabetes. The Libre Duo 10-Day Continuous Dual Glucose Ketone Monitoring System is a pioneering wearable device that marks the first of its kind to be approved in the United States.

This innovative system is not only the first wearable device to monitor ketone levels but also the first to combine the monitoring of ketone and blood sugar levels. The FDA has cleared this device for use in individuals aged 2 and older.

According to the FDA, knowing that ketone levels are rising and having that information in real-time, around the clock, can be the difference between early intervention and a life-threatening emergency. Dr. Michelle Tarver, director of the FDA’s Center for Devices and Radiological Health, emphasized the importance of this breakthrough, stating, ‘Today’s authorization is a breakthrough for the safety of children and adults living with diabetes.’

The U.S. Centers for Disease Control and Prevention estimates that 40.1 million Americans live with diabetes. Approximately 2.1 million of them have type 1 diabetes, which makes it essential to monitor ketone levels. When the body lacks insulin, it uses fat instead of glucose to produce energy, resulting in the creation of ketone, an acid. Elevated ketone levels can lead to diabetic ketoacidosis, a potentially life-threatening complication.

The FDA emphasized the critical importance of early detection of rising ketone levels. Until now, individuals had to rely on separate tests that provided a single measurement at one point in time. In contrast, the new system combines blood sugar and ketone tests and monitors them continuously. The readings, along with alerts for any dangerous trends, are sent wirelessly to a smartphone app.

The FDA previously granted ‘breakthrough device’ status to the system, which aims to expedite the device’s development and review process. This approval is a significant step forward in the management of diabetes, offering individuals with type 1 diabetes a more accurate and efficient way to monitor their condition.

The FDA’s approval of the Libre Duo 10-Day Continuous Dual Glucose Ketone Monitoring System has the potential to revolutionize the way individuals with diabetes manage their condition. By providing real-time monitoring of blood sugar and ketone levels, this device can help prevent life-threatening complications and improve the overall quality of life for those affected by diabetes.

The Centers for Disease Control and Prevention estimates that 40.1 million Americans live with diabetes. Approximately 2.1 million of them have type 1 diabetes, which makes it essential to monitor ketone levels. When the body lacks insulin, it uses fat instead of glucose to produce energy, resulting in the creation of ketone, an acid. Elevated ketone levels can lead to diabetic ketoacidosis, a potentially life-threatening complication.

The FDA’s approval of the Libre Duo 10-Day Continuous Dual Glucose Ketone Monitoring System has the potential to revolutionize the way individuals with diabetes manage their condition. By providing real-time monitoring of blood sugar and ketone levels, this device can help prevent life-threatening complications and improve the overall quality of life for those affected by diabetes.